Publication | Closed Access

Limosilactobacillus mucosae and Lactobacillus amylovorus Protect Against Experimental Colitis via Upregulation of Colonic 5-Hydroxytryptamine Receptor 4 and Transforming Growth Factor-β2

InflammationMucosal ImmunologyMicrobial PathogensLimosilactobacillus MucosaePathogenesisGastroenterologyMicrobial InteractionsMicrobiologyUlcerative ColitisTransforming Growth Factor-β2Intestinal MicrobiotaMedicineGut Barrier